Intrinsiqs

Is Greenwich LifeSciences, Inc. overvalued?

Greenwich LifeSciences, Inc. (GLSI) — key valuation metrics and fundamentals.

No verdict
Price
$14.94
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$219.3M
Dividend yield
0.0%
Return on equity
-793.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GLSI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.